Literature DB >> 11583757

Non-invasive distension of the small bowel for magnetic-resonance imaging.

M A Patak, J M Froehlich, C von Weymarn, M A Ritz, C L Zollikofer, K Wentz.   

Abstract

Magnetic resonance enteroclysis is a promising technique that allows assessment of the small bowel but needs invasive nasoduodenal intubation. We propose a non-invasive distension method for magnetic-resonance imaging (MRI) in which ispaghula, dissolved in an aqueous solution with meglumine gadoterate taken orally over 4 h forms a viscous hydrogel within the intestinal lumen. MRI results from ten volunteers showed good luminal distension, constant signal homogeneity, optimum demarcation of the bowel content from surrounding tissues, and a low rate of artefacts. Our method permits non-invasive high quality MRI of the small bowel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583757     DOI: 10.1016/s0140-6736(01)06127-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

Review 1.  Non-invasive investigation of gastrointestinal functions with magnetic resonance imaging: towards an "ideal" investigation of gastrointestinal function.

Authors:  W Schwizer; M Fox; A Steingötter
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

2.  Combined small and large bowel MR imaging in patients with Crohn's disease: a feasibility study.

Authors:  Burcu Narin; Waleed Ajaj; Susanne Göhde; Jost Langhorst; Haldun Akgöz; Guido Gerken; Stefan G Rühm; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2004-06-18       Impact factor: 5.315

3.  Small bowel obstruction following computed tomography and magnetic resonance enterography using psyllium seed husk as an oral contrast agent.

Authors:  Yingming Amy Chen; Patrick Cervini; Anish Kirpalani; Paraskevi A Vlachou; Samir C Grover; Errol Colak
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

4.  Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging.

Authors:  Arne S Borthne; Michael Abdelnoor; Trygve Storaas; Claude Pierre-Jerome; Nils-E Kløw
Journal:  Eur Radiol       Date:  2006-02-21       Impact factor: 5.315

5.  A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis.

Authors:  Anne Negaard; Vemund Paulsen; Leiv Sandvik; Audun Elnaes Berstad; Arne Borthne; Kirsti Try; Idar Lygren; Tryggve Storaas; Nils-Einar Klow
Journal:  Eur Radiol       Date:  2007-05-05       Impact factor: 5.315

Review 6.  Imaging of the gastrointestinal tract-novel technologies.

Authors:  Jens Brøndum Frøkjaer; Asbjørn Mohr Drewes; Hans Gregersen
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

7.  Computed tomography enterography and magnetic resonance enterography: the future of small bowel imaging.

Authors:  Mark E Baker; David M Einstein; Joseph C Veniero
Journal:  Clin Colon Rectal Surg       Date:  2008-08

8.  Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy.

Authors:  Johannes Sailer; Philipp Peloschek; Walter Reinisch; Harald Vogelsang; Karl Turetschek; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-05-27       Impact factor: 5.315

9.  Comparison of 3% sorbitol vs psyllium fibre as oral contrast agents in MR enterography.

Authors:  Sidharth Saini; Errol Colak; Shalini Anthwal; Paraskevi A Vlachou; Antony Raikhlin; Anish Kirpalani
Journal:  Br J Radiol       Date:  2014-07-25       Impact factor: 3.039

10.  Ultrasonographic detection and assessment of the severity of Crohn's disease recurrence after ileal resection.

Authors:  Nadia Pallotta; Maurizio Giovannone; Patrizio Pezzotti; Alessandro Gigliozzi; Fausto Barberani; Daria Piacentino; Naima Abdulkadir Hassan; Giuseppina Vincoli; Mauro Tosoni; Alfredo Covotta; Adriana Marcheggiano; Mauro Di Camillo; Enrico Corazziari
Journal:  BMC Gastroenterol       Date:  2010-07-01       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.